Podcast interview
Infectious diseases research in Indonesia
Clinical Infectious Diseases research at OUCRU Indonesia addresses prevention, diagnosis and management of complex infectious diseases, focusing on tuberculosis, HIV, and antimicrobial resistance, and other emerging infections. Participation in the RECOVERY trial contributed to the identification of four treatments for severe COVID-19. We are building research expertise and prioritize translating research findings into policy. Our goal is to reduce disease burdens through technical and implementation innovations.
Raph Hamers
MD PhD
Associate Professor in Infectious Diseases
- Interim Director of the Oxford University Clinical Research Unit (OUCRU) Indonesia
- Head of Clinical Infectious Diseases Research Programme, OUCRU Indonesia
- Associate Professor in Infectious Diseases, Nuffield Dept of Medicine, University of Oxford
- Consultant in Internal Medicine and Infectious Diseases
Oxford University Clinical Research Unit (OUCRU) Indonesia
Raph Hamers is the Interim Director of the Oxford University Clinical Research Unit (OUCRU) Indonesia, and also leads its Clinical Infectious Disease Research Programme. He is also an Associate Professor at the University of Oxford's Nuffield Department of Medicine, and an Adjunct Professor at the Faculty of Medicine Universitas Indonesia.
Following his PhD in Medicine at the University of Amsterdam, he was the recipient of a Veni career development fellowship through the Dutch Research Council (NWO) Talent Programme. He also contributes his expertise as an honorary consultant internist and infectious disease physician at the Amsterdam University Medical Centres, and as a consultant for the Antimicrobial Resistance Division at the World Health Organization.
Since 2017, he has spearheaded establishing the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL), embedded in the Faculty of Medicine Universitas Indonesia, in central Jakarta. This research hub aims to strengthen clinical research, training and community engagement capabilities through collaboration with OUCRU Indonesia’s primary partners and the Oxford Tropical Network.
Prof. Hamers' research is wide-ranging across several global health challenges, with a focus on improving health outcomes of complex infectious diseases in low and middle income countries. He has extensive experience as a lead investigator of clinical trials and connected epidemiological, social and laboratory science studies in sub-Saharan Africa and Southeast Asia. His research focuses on antimicrobial resistance and stewardship, prevention and management of HIV, the clinical management of tuberculosis, and other emerging infectious diseases relevant to Indonesia and the region.
He has received funding from the Medical Research Council-UK Research and Innovation (UKRI), Wellcome Trust, US Centre for Disease Prevention and Control, Oxford University, WHO, Dutch Research Council, the Dutch AidsFonds, and other agencies.
Recent publications
Factors influencing antimicrobial stewardship implementation in healthcare facilities in four countries of Southeast Asia: a mixed-methods study (2022-23).
Journal article
Limato R. et al, (2026), The Lancet regional health. Southeast Asia, 53
Mortality and Length of Stay Associated With Community-Acquired Escherichia coli and Staphylococcus aureus Bloodstream Infections: An Observational Study in 9 Low- and Middle-Income Countries
Journal article
Hopkins J. et al, (2026), Clinical Infectious Diseases, 83, e291 - e299
Evaluation of the laboratory assessment process for A Clinically Oriented Antimicrobial Resistance Surveillance Network (ACORN-LAP) in low-income and middle-income countries: a multicountry, cross-sectional analysis with longitudinal quality monitoring
Journal article
Ling CL. et al, (2026), The Lancet Microbe, 101485 - 101485
Aetiology and Antibiotic Susceptibility of Common Bacterial Infections in Hospitalised Patients: A 2019 Multisite Cross‐Sectional Survey in Jakarta, Indonesia
Journal article
de Brabander J. et al, (2026), Tropical Medicine & International Health, 31, 1231 - 1237
Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants
Journal article
Inzaule SC. et al, (2026), Frontiers in Epidemiology, 6
A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment
Journal article
Donovan J. et al, (2026), Journal of Infection, 93, 106796 - 106796
Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.
Journal article
Mo Y. et al, (2026), The Lancet. Infectious diseases
Impact of COVID-19 pandemic on childhood immunization coverage in Indonesia: lesson learned from a nationwide analysis of the Expanded Programme on Immunization.
Journal article
Nurina A. et al, (2026), BMC medicine
Antimicrobial resistance in bacterial pathogens causing community-acquired and hospital-acquired lower respiratory tract infections (2010–24): a systematic review and meta-analysis
Journal article
Lazarus G. et al, (2026), The Lancet Microbe, 7, 101361 - 101361
HIV prevention must incorporate acute HIV infection screening.
Journal article
Hamers RL. et al, (2026), The lancet. HIV, 13